tradingkey.logo

P3 Health Partners Inc

PIII
4.120USD
-0.200-4.63%
收盤 12/19, 16:00美東報價延遲15分鐘
13.46M總市值
虧損本益比TTM

P3 Health Partners Inc

4.120
-0.200-4.63%

關於 P3 Health Partners Inc 公司

P3 Health Partners Inc. is a patient-centered and physician-led population health management company. The Company supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, it creates an enhanced patient experience by navigating, coordinating, and integrating the patient’s care within the healthcare system. Its technology platform, P3 Technology/Health Hub, enables physicians, care teams, patients and their family members to engage in the care journey. P3 Technology/Health Hub integrates clinical and claims data from disparate data points each month from payors, outpatient and inpatient facilities and other ancillary care settings. It has a network of more than 3,100 affiliated primary care providers across the country. Its local teams of healthcare professionals manage the care of thousands of patients in 27 counties across five states.

P3 Health Partners Inc簡介

公司代碼PIII
公司名稱P3 Health Partners Inc
上市日期Feb 10, 2021
CEOCoffman (Aric)
員工數量360
證券類型Ordinary Share
年結日Feb 10
公司地址2045 W Grand Ave Ste B
城市CHICAGO
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編60612-1577
電話13128228897
網址https://ir.p3hp.org/
公司代碼PIII
上市日期Feb 10, 2021
CEOCoffman (Aric)

P3 Health Partners Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Amir Bacchus, M.D.
Dr. Amir Bacchus, M.D.
Co-Founder, Chief Medical Officer, Director
Co-Founder, Chief Medical Officer, Director
45.13K
--
Mr. Gregory D. (Greg) Wasson
Mr. Gregory D. (Greg) Wasson
Independent Director
Independent Director
21.36K
+10.33%
Mr. Mark Alan Thierer
Mr. Mark Alan Thierer
Independent Chairman of the Board
Independent Chairman of the Board
16.85K
+31.13%
Ms. Mary A. Tolan
Ms. Mary A. Tolan
Independent Director
Independent Director
4.17K
+92.34%
Mr. Gregory N. (Greg) Kazarian
Mr. Gregory N. (Greg) Kazarian
Director
Director
4.17K
+92.34%
Mr. Jeffrey Gary (Jeff) Park
Mr. Jeffrey Gary (Jeff) Park
Independent Director
Independent Director
4.17K
+92.34%
Mr. Lawrence B. (Larry) Leisure
Mr. Lawrence B. (Larry) Leisure
Independent Director
Independent Director
--
--
Mr. Leif Pedersen
Mr. Leif Pedersen
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Aric Coffman, M.D.
Dr. Aric Coffman, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Ryan Halstead
Mr. Ryan Halstead
Managing Director
Managing Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Amir Bacchus, M.D.
Dr. Amir Bacchus, M.D.
Co-Founder, Chief Medical Officer, Director
Co-Founder, Chief Medical Officer, Director
45.13K
--
Mr. Gregory D. (Greg) Wasson
Mr. Gregory D. (Greg) Wasson
Independent Director
Independent Director
21.36K
+10.33%
Mr. Mark Alan Thierer
Mr. Mark Alan Thierer
Independent Chairman of the Board
Independent Chairman of the Board
16.85K
+31.13%
Ms. Mary A. Tolan
Ms. Mary A. Tolan
Independent Director
Independent Director
4.17K
+92.34%
Mr. Gregory N. (Greg) Kazarian
Mr. Gregory N. (Greg) Kazarian
Director
Director
4.17K
+92.34%
Mr. Jeffrey Gary (Jeff) Park
Mr. Jeffrey Gary (Jeff) Park
Independent Director
Independent Director
4.17K
+92.34%

收入明細

FY2025Q2
FY2025Q1
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
United States
355.79M
0.00%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 8月22日 週五
更新時間: 8月22日 週五
持股股東
股東類型
持股股東
持股股東
佔比
Chicago Pacific Founders UGP LLC
46.97%
Leavitt Equity Partners II LP
10.84%
Alyeska Investment Group, L.P.
5.50%
The Vanguard Group, Inc.
1.48%
Bacchus (Amir)
1.37%
其他
33.83%
持股股東
持股股東
佔比
Chicago Pacific Founders UGP LLC
46.97%
Leavitt Equity Partners II LP
10.84%
Alyeska Investment Group, L.P.
5.50%
The Vanguard Group, Inc.
1.48%
Bacchus (Amir)
1.37%
其他
33.83%
股東類型
持股股東
佔比
Corporation
57.81%
Hedge Fund
5.50%
Individual Investor
4.27%
Investment Advisor
3.52%
Investment Advisor/Hedge Fund
1.78%
Research Firm
0.10%
其他
27.00%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
140
358.16K
10.96%
-476.81K
2025Q2
159
2.39M
73.22%
-351.07K
2025Q1
163
2.40M
73.55%
-322.33K
2024Q4
164
121.70M
75.84%
-21.19M
2024Q3
165
70.21M
46.23%
-6.58M
2024Q2
165
74.96M
49.19%
+19.75M
2024Q1
158
50.37M
43.55%
+5.90M
2023Q4
154
52.28M
45.78%
+2.36M
2023Q3
212
65.33M
71.01%
-13.71M
2023Q2
211
65.78M
73.28%
-11.63M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Chicago Pacific Founders UGP LLC
1.54M
47.23%
--
--
Jun 04, 2025
Leavitt Equity Partners II LP
356.27K
10.9%
+159.49K
+81.05%
May 24, 2024
Alyeska Investment Group, L.P.
180.91K
5.54%
-1.00
-0.00%
Jun 30, 2025
The Vanguard Group, Inc.
38.36K
1.17%
+1.97K
+5.42%
Jun 30, 2025
Bacchus (Amir)
45.13K
1.38%
--
--
Apr 09, 2025
Corient Private Wealth LLC
35.37K
1.08%
-2.04K
-5.44%
Jun 30, 2025
Abdou (Sherif)
32.16K
0.98%
--
--
Apr 09, 2025
EMFO, LLC
28.55K
0.87%
+8.13K
+39.80%
Jun 30, 2024
Trinity Financial Advisors LLC
26.68K
0.82%
+1.18K
+4.62%
Sep 30, 2025
Wasson (Gregory D)
21.36K
0.65%
+2.00K
+10.33%
Aug 06, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
Global X Russell 2000 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Proshares Ultra Russell 2000
0%
iShares Micro-Cap ETF
0%
Fidelity Nasdaq Composite Index ETF
0%
iShares Russell 2000 Growth ETF
0%
iShares Russell 2000 ETF
0%
ProShares UltraPro Russell2000
佔比0%
ProShares Hedge Replication ETF
佔比0%
Global X Russell 2000 ETF
佔比0%
Global X Russell 2000 Covered Call ETF
佔比0%
Proshares Ultra Russell 2000
佔比0%
iShares Micro-Cap ETF
佔比0%
Fidelity Nasdaq Composite Index ETF
佔比0%
iShares Russell 2000 Growth ETF
佔比0%
iShares Russell 2000 ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
Apr 04, 2025
Merger
50→1
公告日期
類型
比率
Apr 04, 2025
Merger
50→1

常見問題

P3 Health Partners Inc的前五大股東是誰?

P3 Health Partners Inc的前五大股東如下:
Chicago Pacific Founders UGP LLC
持有股份:1.54M
佔總股份比例:47.23%。
Leavitt Equity Partners II LP
持有股份:356.27K
佔總股份比例:10.90%。
Alyeska Investment Group, L.P.
持有股份:180.91K
佔總股份比例:5.54%。
The Vanguard Group, Inc.
持有股份:38.36K
佔總股份比例:1.17%。
Bacchus (Amir)
持有股份:45.13K
佔總股份比例:1.38%。

P3 Health Partners Inc的前三大股東類型是什麼?

P3 Health Partners Inc 的前三大股東類型分別是:
Chicago Pacific Founders UGP LLC
Leavitt Equity Partners II LP
Alyeska Investment Group, L.P.

有多少機構持有P3 Health Partners Inc(PIII)的股份?

截至2025Q3,共有140家機構持有P3 Health Partners Inc的股份,合計持有的股份價值約為358.16K,占公司總股份的10.96% 。與2025Q2相比,機構持股有所增加,增幅為-62.26%。

哪個業務部門對P3 Health Partners Inc的收入貢獻最大?

在FY2025Q2,--業務部門對P3 Health Partners Inc的收入貢獻最大,創收--,占總收入的--% 。
KeyAI